Home Trending Stocks Why Jaguar Health Inc (JAGX) stock went up on Tuesday?

Why Jaguar Health Inc (JAGX) stock went up on Tuesday?

Jaguar Health Inc (JAGX) stock performed well on Tuesday, May 25, 2021. JAGX stock gained 2.01% in the early trading session on Tuesday and later in the after-hours, it further gained 5.26% to close the day at $1.6 per share.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

JAGX shares have risen 249.43% over the last 12 months, and they have moved up 22.58% in the past week. Over the past three months, the stock has lost 36.13%, while over the past six months, it has soared 637.51%.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Let’s check out its recent developments.

Abstract presentation at upcoming ASCO annual meeting

On May 20, 2021, Jaguar Health, Inc announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea (“CRD”) by Napo Pharmaceuticals, Inc which is Jaguar’s wholly-owned subsidiary.

Read More

The abstract “the impact of cancer-related diarrhea on changes in cancer therapy patterns: Real-world evidence” also has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO®) Annual Meeting, which will be held virtually from June 4-8, 2021.

New social media channel for Jaguar health community

On May 19, 2021, Jaguar Health, Inc launched a new social media channel, Jaguar Health Community’s Instagram page, which will work as a central social media hub for stakeholders and the Company’s growing community of followers.

Recent updates about Canalevia (Crofelemer)

On May 18, 2021, Jaguar Health, Inc provided updates regarding the development program for the Company’s oral plant-based drug candidate Canaleviawhich is used to treat chemotherapy-induced diarrhea (CID) in dogs and exercise-induced diarrhea (EID) in dogs.

Recent financial results

On May 17, 2021, Jaguar Health, Inc released its consolidated first quarter 2021 financial results.

Q1 2021 financial highlights

  • Jaguar Health earned net product revenue of $1.241 million in Q1 2021, compared to $0.87 million in Q1 2020.
  • Operating loss was $8.8 million in Q1 2021 compared to $7.7 million operating loss in Q1 2020.
  • The company reported a net loss of $12 million or $0.10 per basic and diluted share in Q1 2021 compared to a net loss of $7.9 million or $0.56 per basic and diluted share in Q1 2020.
  • The total cost of product revenue for the quarter ended March 31, 2021, was $0.6 million compared to $0.7 million for the quarter ended March 31, 2020.
  • Non-GAAP EBITDA for the first quarter of 2021 was a net loss of $9.0 million compared to a net loss of $6.5 million in Q1 2020. 

Inducement Grants

On May 14, 2021, Jaguar Health, Inc granted non-statutory stock options for the purchase of up to 4,000 shares of the Company’s common stock to New Employee 1, non-statutory stock options for the purchase of up to 4,750 shares of the Company’s common stock to New Employee 2, and non-statutory stock options for the purchase of up to 40,000 shares of the Company’s common stock to New Employee at an exercise price of $1.22 per share.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Well, as of this writing, there is no recent news which could justify its positive performance on Tuesday. We hope that JAGX will continue its momentum on Wednesday as well.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Vista Gold Corp. (VGZ) stock soars during pre-market trading. Here’s what you should know

Vista Gold Corp. (NASDAQ: VGZ) stock gained by 17.65% in the pre-market trading session. Vista is a project developer with a gold rating. The...

Novan Inc. (NOVN) stock soars during pre-market trading. What’s driving it high?

Novan Inc. (NASDAQ: NOVN) stock gained by 62.39% at last close whereas the NOVN stock price surged by 0.82% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?

Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%....

Related News

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Vista Gold Corp. (VGZ) stock soars during pre-market trading. Here’s what you should know

Vista Gold Corp. (NASDAQ: VGZ) stock gained by 17.65% in the pre-market trading session. Vista is a project developer with a gold rating. The...

Novan Inc. (NOVN) stock soars during pre-market trading. What’s driving it high?

Novan Inc. (NASDAQ: NOVN) stock gained by 62.39% at last close whereas the NOVN stock price surged by 0.82% in the pre-market trading session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam